Navigation Links
Urinary Tract Infection Market (UTI): Gram-Negative Bacterial 2022 Epidemiology Forecasts in New Research Report at RnRMarketResearch.com
Date:11/21/2013

Dallas, Texas (PRWEB) November 21, 2013

Urinary tract infections (UTIs) are among the most common bacterial infections acquired in hospitals and in the community setting (Foxman, 2010). Globally, an estimated 150 million UTIs occur annually, resulting in over six billion dollars in direct healthcare expenditures (Stamm and Norrby, 2001). In the US alone, UTI results in nearly seven million office visits, and one million emergency department visits each year (Foxman, 2002). A UTI can occur when daily living activities and medical interventions aid in the movement of bacteria into the urethra; however, bacterial colonization does not always lead to the development of UTI symptoms (Foxman, 2010). Although UTIs can be caused by bacteria, viruses, or fungi, gram-negative bacteria are the pathogens most frequently associated with UTIs (Gaynes et al., 2005). Gram-negative bacteria have become increasingly resistant to individual antimicrobials, and of particular concern, is the emergence of multidrug-resistant activity in these organisms (D’Agata, 2004). Although there has been little change in the predominant causative pathogens in the past few decades, individual pathogen frequency and resistance patterns of gram-negative pathogens vary considerably between settings, countries, and continents (Gupta et al., 2001; Ortega et al., 2013; Ronald, 2002; Shigemura et al., 2005).

Complete report available @ http://www.rnrmarketresearch.com/epicast-report-gram-negative-bacterial-urinary-tract-infection-epidemiology-forecast-to-2022-market-report.html .

This report provides an overview of the risk factors for UTI in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan), and includes a 10-year epidemiological forecast for incident cases of UTI segmented by age (0–=85 years), sex, causative pathogen (Escherichia coli, Klebsiella, Pseudomonas aeruginosa, Proteus, and Acinetobacter), multidrug resistance, and carbapenem resistance in these markets. The forecast in the US is focused on incident cases caused by gram-negative bacteria in three sites of acquisition (nosocomial, healthcare-associated, and community-acquired), the 5EU (France, Germany, Italy, Spain, and UK) forecast is focused on healthcare-associated UTI incident cases caused by all pathogens, and the forecast in Japan includes incident cases caused by all pathogens that were diagnosed in intensive care units (ICUs).

According to forecast, the number of incident cases of UTI will increase in the US during the forecast period. The largest number of cases will be classified as community-acquired and occur in women =80 years of age. The 5EU will see a slight increase in the number of healthcare-associated incident cases of UTI during the forecast period, with the highest number of cases occurring among women in Germany, and among those ages 70–79 years. Moreover, the most prevalent causative pathogen will be E. coli. Japan is forecast to see a large increase in the number of incident cases of UTI occurring during the forecast period in ICUs, with the greatest number of cases occurring among women and those =80 years. Similar to the US and the 5EU, GlobalData epidemiologists expect that E. coli will be the most prevalent causative pathogen in this market.

A major strength of this analysis is that epidemiologists used country-specific sources for each market in the analysis and were able to obtain country-specific national surveillance data for the 5EU and Japan. The use of country-specific sources is especially important for antimicrobial resistance data as the rates of resistance have been found to vary considerably between countries. Additionally, because resistance rates have changed over time, GlobalData’s use of recent sources for resistance rates ensures that the estimates for the number of resistant cases of UTI reflect the most current situation in each market.

Scope

  •     The Gram-Negative Bacterial Urinary Tract Infection (UTI) EpiCast Report provides an overview of the risk factors and global trends of UTI in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiology forecast of UTI incident cases segmented by age (0-85 years and older), sex, causative pathogen (Escherichia coli, Klebsiella, Pseudomonas aeruginosa, Proteus, and Acinetobacter), multidrug resistance, and carbapenem resistance in these markets.
  •     The UTI epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  •     The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

  •     Develop business strategies by understanding the trends shaping and driving the global UTI market.
  •     Quantify patient populations in the global UTI market to improve product design, pricing, and launch plans.
  •     Organize sales and marketing efforts by identifying the sex, age groups, pathogens, and antibiotic resistance patterns that present the best opportunities for UTI therapeutics in each of the markets covered.

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=131521 .

Browse more reports on Renal therapeutics Market @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/kidney/kidneyrenal-therapeutics .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/gram-negative-bacterial/urinary-tract-infection/prweb11357137.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Urinary Incontinence Drugs May Be More Trouble Than Theyre Worth
2. Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk
3. Discovery helps mice beat urinary tract infections
4. A non-antibiotic approach for treating urinary tract infections
5. As a mans belt size increases, so does his risk of sexual and urinary dysfunction
6. A nonantibiotic approach for treating urinary tract infections
7. U-M guidelines help family physicians evaluate, manage urinary incontinence for women
8. How Long Should Mens Urinary Infections Be Treated?
9. Microscopic blood in urine unreliable indicator of urinary tract cancer
10. Prostate cancer study tracks long-term urinary, sexual and bowel function side effects
11. UroToday Launches New Online Urologic Catheter Resource Center, Featuring Indwelling Urinary Catheters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... This campaign aims to provide a path to ... society can control and change. , As nearly 795,000 Americans suffering from a new ... United States. Plus, with an estimated 129,000 of these people dying from stroke, it’s ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... bolstered by inspiring human interest stories, courtesy of leaders in the nursing and ... within the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... Despite last ... meeting, expect Janet Yellen and company to wait until March 2017 for an interest ... University’s J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... outcomes, hosted members and suppliers for its inaugural Member Conference at the Paris ... mission of elevating the operational health of America’s healthcare providers. , The conference ...
(Date:5/26/2016)... ... May 26, 2016 , ... The Woodlands at John ... a new model of care for living and healing, celebrated its grand opening, today. ... in a Real Home provided by Empowered Staff. , “This is an incredibly fulfilling ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... 25, 2016 According to market ... Growth and Demand Forecast to 2022 - Industry Insights ... Others)" published by P&S Market Research, the global insulin ... 2015, and it is expected to grow at a ... insulin pump segment is expected to witness the fastest ...
(Date:5/25/2016)... Digital Health Dialog, LLC dba EngagedMedia ... US Patent and Trademark Office of U.S. Patent ... for electronic opt-­in and processing of discount coupons ... compliance and otherwise. Logo - http://photos.prnewswire.com/prnh/20160524/371583LOGO ... "Our technology allows for individuals to opt­-in to ...
(Date:5/25/2016)... ReportsnReports.com adds "Chronic Cough ... provides an overview on therapeutic pipeline of Chronic ... therapeutics assessment by drug target, mechanism of action ... along with latest updates, and featured news and ... in the therapeutic development for Chronic Cough and ...
Breaking Medicine Technology: